Cisplatin in cancer treatment

AMP Romani - Biochemical pharmacology, 2022 - Elsevier
Cisplatin is a widely used chemotherapy agent in the treatment of various forms of
carcinomas and sarcomas. Its effectiveness in delaying negative outcome in cancer patients …

Mechanisms of cisplatin-induced acute kidney injury: pathological mechanisms, pharmacological interventions, and genetic mitigations

KR McSweeney, LK Gadanec, T Qaradakhi, BA Ali… - Cancers, 2021 - mdpi.com
Simple Summary Nephrotoxicity is the dose-limiting factor of cisplatin treatment.
Nephrotoxicity is characterized by reduced kidney function. Although an often-reversible …

The drug-resistance mechanisms of five platinum-based antitumor agents

J Zhou, Y Kang, L Chen, H Wang, J Liu… - Frontiers in …, 2020 - frontiersin.org
Platinum-based anticancer drugs, including cisplatin, carboplatin, oxaliplatin, nedaplatin,
and lobaplatin, are heavily applied in chemotherapy regimens. However, the intrinsic or …

Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy

T Makovec - Radiology and oncology, 2019 - sciendo.com
Background. Platinum-based anticancer drugs are widely used in the chemotherapy of
human neoplasms. The major obstacle for the clinical use of this class of drugs is the …

Organic cation transporters in health and disease

H Koepsell - Pharmacological reviews, 2020 - ASPET
The organic cation transporters (OCTs) OCT1, OCT2, OCT3, novel OCT (OCTN) 1, OCTN2,
multidrug and toxin exclusion (MATE) 1, and MATE kidney-specific 2 are polyspecific …

Mechanisms of cisplatin nephrotoxicity

RP Miller, RK Tadagavadi, G Ramesh, WB Reeves - Toxins, 2010 - mdpi.com
Cisplatin is a widely used and highly effective cancer chemotherapeutic agent. One of the
limiting side effects of cisplatin use is nephrotoxicity. Research over the past 10 years has …

Xenobiotic, bile acid, and cholesterol transporters: function and regulation

CD Klaassen, LM Aleksunes - Pharmacological reviews, 2010 - ASPET
Transporters influence the disposition of chemicals within the body by participating in
absorption, distribution, and elimination. Transporters of the solute carrier family (SLC) …

Renal drug transporters and drug interactions

A Ivanyuk, F Livio, J Biollaz, T Buclin - Clinical pharmacokinetics, 2017 - Springer
Transporters in proximal renal tubules contribute to the disposition of numerous drugs.
Furthermore, the molecular mechanisms of tubular secretion have been progressively …

Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications

H Koepsell, K Lips, C Volk - Pharmaceutical research, 2007 - Springer
The body is equipped with broad-specificity transporters for the excretion and distribution of
endogeneous organic cations and for the uptake, elimination and distribution of cationic …

[HTML][HTML] Organic cation transporter 2 mediates cisplatin-induced oto-and nephrotoxicity and is a target for protective interventions

G Ciarimboli, D Deuster, A Knief, M Sperling… - The American journal of …, 2010 - Elsevier
The use of the effective antineoplastic agent cisplatin is limited by its serious side effects,
such as oto-and nephrotoxicity. Ototoxicity is a problem of special importance in children …